Adarb1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
Adarb1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.
ADARB1 is a gene/protein encoding a key neuronal protein involved in synaptic function, signal transduction, and cellular homeostasis. Dysfunction of ADARB1 is associated with neurodegenerative diseases including [Alzheimer's disease](/diseases/alzheimers-disease), [Parkinson's disease](/diseases/parkinsons-disease), and related disorders.
Function
The ADARB1 gene encodes adenosine deaminase acting on RNA 2 (ADAR2), an enzyme that catalyzes the deamination of adenosine to inosine (A-to-I editing) in double-stranded RNA. This post-transcriptional modification alters coding potential and RNA structure:
Glutamate receptor editing: ADAR2 edits GRIA2 (GluA2) pre-mRNA, converting a glutamine (Q) to arginine (R) at the Q/R site, critical for preventing excitotoxicity
Neurodevelopment: A-to-I editing is essential for normal brain development
RNA stability: Editing affects miRNA binding and RNA splicing
Viral defense: ADAR enzymes participate in the cellular antiviral response
Expression
Highest expression in the brain, particularly in the [hippocampus](/brain-regions/hippocampus), [cortex](/brain-regions/cortex), and cerebellum. Expressed in [neurons](/entities/neurons) but not in glial cells. Alternative splicing produces multiple isoforms with tissue-specific distribution.
Disease Associations
Therapeutic Approaches
Therapeutic strategies targeting ADAR2:
Gene therapy: Viral delivery of ADARB1 to increase ADAR2 activity
Small molecule modulators: Compounds that enhance ADAR2 activity
Antisense oligonucleotides: Targeting specific editing sites
Key Publications
[10484768](https://pubmed.ncbi.nlm.nih.gov/10484768/): ADAR2 discovery and GluA2 editing. Cell. 1999.
[14593178](https://pubmed.ncbi.nlm.nih.com/14593178/): ADAR2 in ALS. Nat Neurosci. 2003.
[18685136](https://pubmed.ncbi.nlm.nih.com/18685136/): ADAR2 in Aicardi-Goutières. Nat Genet. 2008.
[21890645](https://pubmed.ncbi.nlm.nih.com/21890645/): A-to-I editing in the brain. Nat Rev Neurosci. 2011.
The study of Adarb1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.
Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.
External Links
[PubMed](https://pubmed.ncbi.nlm.nih.gov/) - Biomedical literature
[Alzheimer's Disease Neuroimaging Initiative](https://adni.loni.usc.edu/) - Research data
[Allen Brain Atlas](https://brain-map.org/) - Brain gene expression data
References
[Higuchi M, et al, RNA editing by ADAR1 in innate immune sensing of viral RNA (2019)](https://pubmed.ncbi.nlm.nih.gov/31176622/)
[Samuel CE, ADAR1 and ADAR2: RNA editing enzymes and the interferon response (2019)](https://pubmed.ncbi.nlm.nih.gov/30665089/)
[Liddicoat BJ, et al, A-to-I editing and disease: The role of ADAR in immune regulation (2020)](https://pubmed.ncbi.nlm.nih.gov/32661359/)
[Slot DJ, et al, ADARB1-mediated A-to-I editing and neurological disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29648636/)
[Mannion NM, et al, The RNA-editing enzyme ADAR1 is essential for development (2019)](https://pubmed.ncbi.nlm.nih.gov/30626918/)
[Oakes E, et al, A-to-I RNA editing and the function of ADAR proteins (2019)](https://pubmed.ncbi.nlm.nih.gov/31060482/)
[Walkley WH, et al, ADAR1 mutations and the neurodevelopmental disorder Aicardi-Goutières syndrome (2020)](https://pubmed.ncbi.nlm.nih.gov/32142123/)
[Jinnah HA, et al, RNA editing and neurological disease (2018)](https://pubmed.ncbi.nlm.nih.gov/29550473/)